Review



anti-psd95 rabbit pab (post synaptic density protein 95)  (Servicebio Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Servicebio Inc anti-psd95 rabbit pab (post synaptic density protein 95)
    L-DOPA treatment significantly increased the levels of GFAP and synaptic-associated proteins (SYP, <t>PSD95,</t> SAP97), but not vasculature, in the lesioned striatum. (A) Representative western blots of TH, GFAP, VEGF, and synaptic associated proteins in the lesioned striatum of the three groups. GAPDH served as the internal control. (B–G) Quantitative analysis of the aforementioned proteins. Data were presented as% of the sham group. * P < 0.05, ** P < 0.01, **** P < 0.0001 vs. the specified or sham group; ## P < 0.01 vs. the PD group. All results were presented as mean ± SEM ( N = 4/group).
    Anti Psd95 Rabbit Pab (Post Synaptic Density Protein 95), supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-psd95+rabbit+pab+(post+synaptic+density+protein+95)/psd+95+antibody/pmc08581620-92-50-59
    Average 90 stars, based on 1 article reviews
    anti-psd95 rabbit pab (post synaptic density protein 95) - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry"

    Article Title: Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry

    Journal: Frontiers in Aging Neuroscience

    doi: 10.3389/fnagi.2021.759934

    L-DOPA treatment significantly increased the levels of GFAP and synaptic-associated proteins (SYP, PSD95, SAP97), but not vasculature, in the lesioned striatum. (A) Representative western blots of TH, GFAP, VEGF, and synaptic associated proteins in the lesioned striatum of the three groups. GAPDH served as the internal control. (B–G) Quantitative analysis of the aforementioned proteins. Data were presented as% of the sham group. * P < 0.05, ** P < 0.01, **** P < 0.0001 vs. the specified or sham group; ## P < 0.01 vs. the PD group. All results were presented as mean ± SEM ( N = 4/group).
    Figure Legend Snippet: L-DOPA treatment significantly increased the levels of GFAP and synaptic-associated proteins (SYP, PSD95, SAP97), but not vasculature, in the lesioned striatum. (A) Representative western blots of TH, GFAP, VEGF, and synaptic associated proteins in the lesioned striatum of the three groups. GAPDH served as the internal control. (B–G) Quantitative analysis of the aforementioned proteins. Data were presented as% of the sham group. * P < 0.05, ** P < 0.01, **** P < 0.0001 vs. the specified or sham group; ## P < 0.01 vs. the PD group. All results were presented as mean ± SEM ( N = 4/group).

    Techniques Used: Western Blot

    L-DOPA treatment promoted astrocytic and synaptic pathology in the lesioned striatum. (A) TH immunostaining of the striatum in each group. (C,E,G,I) Representative immunohistochemical images of GFAP, VEGF, and synaptic associated proteins (SYP, PSD95) of the dorsolateral striatum from the three groups in the lesioned side. [Scale bars: (A) is 1 mm, (C,E,G,I) is 50 μm]. (B,D,F,H,J) Analysis of differences of the aforementioned proteins. AOD, average optical density. Results were expressed as % of the unlesioned side. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 vs. the specified group. Error bars represent SEM ( N = 3/group).
    Figure Legend Snippet: L-DOPA treatment promoted astrocytic and synaptic pathology in the lesioned striatum. (A) TH immunostaining of the striatum in each group. (C,E,G,I) Representative immunohistochemical images of GFAP, VEGF, and synaptic associated proteins (SYP, PSD95) of the dorsolateral striatum from the three groups in the lesioned side. [Scale bars: (A) is 1 mm, (C,E,G,I) is 50 μm]. (B,D,F,H,J) Analysis of differences of the aforementioned proteins. AOD, average optical density. Results were expressed as % of the unlesioned side. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 vs. the specified group. Error bars represent SEM ( N = 3/group).

    Techniques Used: Immunostaining, Immunohistochemical staining

    Related Articles

    Incubation:

    Article Title: Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
    Article Snippet: After washing, the membranes were incubated using the following primary antibodies overnight at 4°C: anti-TH Rabbit pAb (Tyrosine hydroxylase, 1:3000, Proteintech, 25859-1-AP); anti-GFAP Mouse mAb (glial fibrillary acidic protein, 1:2500, Servicebio, GB12096); anti-VEGF Mouse mAb (vascular endothelial growth factor, 1:200, Santa Cruz, sc-7269); anti-SYP Rabbit pAb (synaptophysin, 1:10000, Servicebio, GB11553); anti-PSD95 Rabbit pAb (post synaptic density protein 95, 1:500, Servicebio, GB11277); anti-SAP97 Rabbit pAb (synapse-associated protein 97, 1:2000, Abcam, ab3437); anti-GAPDH Rabbit pAb (glyceraldehyde 3-phosphate dehydrogenase, 1:10000, GeneTex, GTX100118).

    Western Blot:

    Article Title: Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
    Article Snippet: After washing, the membranes were incubated using the following primary antibodies overnight at 4°C: anti-TH Rabbit pAb (Tyrosine hydroxylase, 1:3000, Proteintech, 25859-1-AP); anti-GFAP Mouse mAb (glial fibrillary acidic protein, 1:2500, Servicebio, GB12096); anti-VEGF Mouse mAb (vascular endothelial growth factor, 1:200, Santa Cruz, sc-7269); anti-SYP Rabbit pAb (synaptophysin, 1:10000, Servicebio, GB11553); anti-PSD95 Rabbit pAb (post synaptic density protein 95, 1:500, Servicebio, GB11277); anti-SAP97 Rabbit pAb (synapse-associated protein 97, 1:2000, Abcam, ab3437); anti-GAPDH Rabbit pAb (glyceraldehyde 3-phosphate dehydrogenase, 1:10000, GeneTex, GTX100118).

    Immunostaining:

    Article Title: Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
    Article Snippet: After washing, the membranes were incubated using the following primary antibodies overnight at 4°C: anti-TH Rabbit pAb (Tyrosine hydroxylase, 1:3000, Proteintech, 25859-1-AP); anti-GFAP Mouse mAb (glial fibrillary acidic protein, 1:2500, Servicebio, GB12096); anti-VEGF Mouse mAb (vascular endothelial growth factor, 1:200, Santa Cruz, sc-7269); anti-SYP Rabbit pAb (synaptophysin, 1:10000, Servicebio, GB11553); anti-PSD95 Rabbit pAb (post synaptic density protein 95, 1:500, Servicebio, GB11277); anti-SAP97 Rabbit pAb (synapse-associated protein 97, 1:2000, Abcam, ab3437); anti-GAPDH Rabbit pAb (glyceraldehyde 3-phosphate dehydrogenase, 1:10000, GeneTex, GTX100118).

    Immunohistochemical staining:

    Article Title: Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
    Article Snippet: After washing, the membranes were incubated using the following primary antibodies overnight at 4°C: anti-TH Rabbit pAb (Tyrosine hydroxylase, 1:3000, Proteintech, 25859-1-AP); anti-GFAP Mouse mAb (glial fibrillary acidic protein, 1:2500, Servicebio, GB12096); anti-VEGF Mouse mAb (vascular endothelial growth factor, 1:200, Santa Cruz, sc-7269); anti-SYP Rabbit pAb (synaptophysin, 1:10000, Servicebio, GB11553); anti-PSD95 Rabbit pAb (post synaptic density protein 95, 1:500, Servicebio, GB11277); anti-SAP97 Rabbit pAb (synapse-associated protein 97, 1:2000, Abcam, ab3437); anti-GAPDH Rabbit pAb (glyceraldehyde 3-phosphate dehydrogenase, 1:10000, GeneTex, GTX100118).



    Similar Products

    anti-psd95 rabbit pab (post synaptic density protein 95)  (Servicebio Inc)
    90
    Servicebio Inc anti-psd95 rabbit pab (post synaptic density protein 95)
    L-DOPA treatment significantly increased the levels of GFAP and synaptic-associated proteins (SYP, <t>PSD95,</t> SAP97), but not vasculature, in the lesioned striatum. (A) Representative western blots of TH, GFAP, VEGF, and synaptic associated proteins in the lesioned striatum of the three groups. GAPDH served as the internal control. (B–G) Quantitative analysis of the aforementioned proteins. Data were presented as% of the sham group. * P < 0.05, ** P < 0.01, **** P < 0.0001 vs. the specified or sham group; ## P < 0.01 vs. the PD group. All results were presented as mean ± SEM ( N = 4/group).
    Anti Psd95 Rabbit Pab (Post Synaptic Density Protein 95), supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-psd95+rabbit+pab+(post+synaptic+density+protein+95)/psd+95+antibody/pmc08581620-92-50-59
    Average 90 stars, based on 1 article reviews
    anti-psd95 rabbit pab (post synaptic density protein 95) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    L-DOPA treatment significantly increased the levels of GFAP and synaptic-associated proteins (SYP, PSD95, SAP97), but not vasculature, in the lesioned striatum. (A) Representative western blots of TH, GFAP, VEGF, and synaptic associated proteins in the lesioned striatum of the three groups. GAPDH served as the internal control. (B–G) Quantitative analysis of the aforementioned proteins. Data were presented as% of the sham group. * P < 0.05, ** P < 0.01, **** P < 0.0001 vs. the specified or sham group; ## P < 0.01 vs. the PD group. All results were presented as mean ± SEM ( N = 4/group).

    Journal: Frontiers in Aging Neuroscience

    Article Title: Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry

    doi: 10.3389/fnagi.2021.759934

    Figure Lengend Snippet: L-DOPA treatment significantly increased the levels of GFAP and synaptic-associated proteins (SYP, PSD95, SAP97), but not vasculature, in the lesioned striatum. (A) Representative western blots of TH, GFAP, VEGF, and synaptic associated proteins in the lesioned striatum of the three groups. GAPDH served as the internal control. (B–G) Quantitative analysis of the aforementioned proteins. Data were presented as% of the sham group. * P < 0.05, ** P < 0.01, **** P < 0.0001 vs. the specified or sham group; ## P < 0.01 vs. the PD group. All results were presented as mean ± SEM ( N = 4/group).

    Article Snippet: After washing, the membranes were incubated using the following primary antibodies overnight at 4°C: anti-TH Rabbit pAb (Tyrosine hydroxylase, 1:3000, Proteintech, 25859-1-AP); anti-GFAP Mouse mAb (glial fibrillary acidic protein, 1:2500, Servicebio, GB12096); anti-VEGF Mouse mAb (vascular endothelial growth factor, 1:200, Santa Cruz, sc-7269); anti-SYP Rabbit pAb (synaptophysin, 1:10000, Servicebio, GB11553); anti-PSD95 Rabbit pAb (post synaptic density protein 95, 1:500, Servicebio, GB11277); anti-SAP97 Rabbit pAb (synapse-associated protein 97, 1:2000, Abcam, ab3437); anti-GAPDH Rabbit pAb (glyceraldehyde 3-phosphate dehydrogenase, 1:10000, GeneTex, GTX100118).

    Techniques: Western Blot

    L-DOPA treatment promoted astrocytic and synaptic pathology in the lesioned striatum. (A) TH immunostaining of the striatum in each group. (C,E,G,I) Representative immunohistochemical images of GFAP, VEGF, and synaptic associated proteins (SYP, PSD95) of the dorsolateral striatum from the three groups in the lesioned side. [Scale bars: (A) is 1 mm, (C,E,G,I) is 50 μm]. (B,D,F,H,J) Analysis of differences of the aforementioned proteins. AOD, average optical density. Results were expressed as % of the unlesioned side. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 vs. the specified group. Error bars represent SEM ( N = 3/group).

    Journal: Frontiers in Aging Neuroscience

    Article Title: Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry

    doi: 10.3389/fnagi.2021.759934

    Figure Lengend Snippet: L-DOPA treatment promoted astrocytic and synaptic pathology in the lesioned striatum. (A) TH immunostaining of the striatum in each group. (C,E,G,I) Representative immunohistochemical images of GFAP, VEGF, and synaptic associated proteins (SYP, PSD95) of the dorsolateral striatum from the three groups in the lesioned side. [Scale bars: (A) is 1 mm, (C,E,G,I) is 50 μm]. (B,D,F,H,J) Analysis of differences of the aforementioned proteins. AOD, average optical density. Results were expressed as % of the unlesioned side. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 vs. the specified group. Error bars represent SEM ( N = 3/group).

    Article Snippet: After washing, the membranes were incubated using the following primary antibodies overnight at 4°C: anti-TH Rabbit pAb (Tyrosine hydroxylase, 1:3000, Proteintech, 25859-1-AP); anti-GFAP Mouse mAb (glial fibrillary acidic protein, 1:2500, Servicebio, GB12096); anti-VEGF Mouse mAb (vascular endothelial growth factor, 1:200, Santa Cruz, sc-7269); anti-SYP Rabbit pAb (synaptophysin, 1:10000, Servicebio, GB11553); anti-PSD95 Rabbit pAb (post synaptic density protein 95, 1:500, Servicebio, GB11277); anti-SAP97 Rabbit pAb (synapse-associated protein 97, 1:2000, Abcam, ab3437); anti-GAPDH Rabbit pAb (glyceraldehyde 3-phosphate dehydrogenase, 1:10000, GeneTex, GTX100118).

    Techniques: Immunostaining, Immunohistochemical staining